[ASAP] Improved Melatonin Delivery by a Size-Controlled Polydopamine Nanoformulation Attenuates Preclinical Diabetic Retinopathy

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c01039
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Source Type: research